Analogic Corporation (NASDAQ:ALOG) Stock Is Shorted More

June 17, 2018 - By Louis Casey

Analogic Corporation (NASDAQ:ALOG) Logo

Investors sentiment increased to 1.82 in 2018 Q1. Its up 0.57, from 1.25 in 2017Q4. It is positive, as 6 investors sold Analogic Corporation shares while 51 reduced holdings. 49 funds opened positions while 55 raised stakes. 11.16 million shares or 1.47% less from 11.33 million shares in 2017Q4 were reported.
Jefferies Gru has invested 0% in Analogic Corporation (NASDAQ:ALOG). Stevens Capital Management Lp has 3,468 shares. Washington Tru Bank & Trust holds 133 shares. Invesco Limited holds 67,489 shares or 0% of its portfolio. 5,900 are owned by Grantham Mayo Van Otterloo & Ltd Company. 12,711 are owned by Hbk Investments Limited Partnership. Goldman Sachs Group Incorporated accumulated 47,860 shares or 0% of the stock. Vanguard Gp Inc accumulated 0.01% or 1.23M shares. Element Cap Management Ltd Liability Corporation has invested 0.01% in Analogic Corporation (NASDAQ:ALOG). Robeco Institutional Asset Mgmt Bv reported 0.01% of its portfolio in Analogic Corporation (NASDAQ:ALOG). Citadel Advsr Ltd stated it has 0% in Analogic Corporation (NASDAQ:ALOG). M&T Savings Bank Corp invested in 0% or 3,490 shares. Piermont Capital Management holds 0.13% or 4,010 shares. Ftb holds 415 shares or 0% of its portfolio. Moreover, Texas Permanent School Fund has 0.01% invested in Analogic Corporation (NASDAQ:ALOG).

The stock of Analogic Corporation (NASDAQ:ALOG) registered an increase of 103.77% in short interest. ALOG’s total short interest was 210,700 shares in June as published by FINRA. Its up 103.77% from 103,400 shares, reported previously. With 359,700 shares average volume, it will take short sellers 1 days to cover their ALOG’s short positions. The short interest to Analogic Corporation’s float is 1.7%.

The stock increased 0.06% or $0.05 during the last trading session, reaching $83.95. About 223,761 shares traded. Analogic Corporation (NASDAQ:ALOG) has risen 16.19% since June 17, 2017 and is uptrending. It has outperformed by 3.62% the S&P500.

Analogic Corporation designs, manufactures, and sells medical imaging systems, ultrasound and security systems, and subsystems to original equipment manufacturers and end users primarily for the medical and airport security markets worldwide. The company has market cap of $1.05 billion. It operates in three divisions: Medical Imaging, Ultrasound, and Security and Detection. It currently has negative earnings. The Medical Imaging segment offers computed tomography (CT) detector systems, data acquisition systems, data management systems, and integrated CT systems; magnetic resonance imaging products, including gradient and radio frequency amplifiers; and digital mammography products, such as detector plates, as well as motion control devices for use in computer-controlled automation systems primarily for the semiconductor, food and beverage, and laboratory automation markets.

More notable recent Analogic Corporation (NASDAQ:ALOG) news were published by: Streetinsider.com which released: “Analogic (ALOG) Says ISS and Glass Lewis Recommend Shareholders Vote for Proposed Acquisition by Affiliate of …” on June 11, 2018, also Nasdaq.com with their article: “Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Analogic Shareholders Vote “For” Proposed Analogic …” published on June 11, 2018, Seekingalpha.com published: “PVAC +3.7%, FLT +4.5% on index changes; NVDA to S&P 100” on June 15, 2018. More interesting news about Analogic Corporation (NASDAQ:ALOG) were released by: Globenewswire.com and their article: “Analogic Introduces Its Newest RF Amplifier for 1.5 Tesla MRI Systems” published on June 15, 2018 as well as Globenewswire.com‘s news article titled: “New Research Coverage Highlights Seaboard, The Hanover Insurance Group, Atara Biotherapeutics, Plexus, NV5 …” with publication date: May 29, 2018.

Analogic Corporation (NASDAQ:ALOG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: